Related Experiment Video
Updated: Jan 22, 2026

Screening Bioactive Nanoparticles in Phagocytic Immune Cells for Inhibitors of Toll-like Receptor Signaling
Published on: July 26, 2017
LRRC62 attenuates Toll-like receptor signaling by deubiquitinating TAK1 via CYLD
Jindong Zhang1, Jiayu Ou2, Xiaoye Wan3
1Immunotherapy Institute, Fujian Medical University, Fuzhou, 350004, PR China; School of Basic Medical Science, Fujian Medical University, Fuzhou, 350004, PR China; Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, 510080, PR China.
Abstract:
TGF-β-activated kinase 1 (TAK1) plays a pivotal role in Toll-like receptor (TLR) signaling pathway. However, the mechanisms controlling its activity remain poorly understood. Here, we show that leucine-rich repeat containing 62 (LRRC62), a previously uncharacterized protein, negatively regulates TLR signaling by targeting TAK1. Expression of LRRC62 inhibits the TLRs-induced production of pro-inflammatory cytokine, whereas deficiency in LRRC62 enhances the activation of NF-κB and MAPK signaling and increases the production of pro-inflammatory cytokines. Mechanically, LRRC62 functions as an adaptor to recruit deubiquitinase CYLD to TAK1, thus inhibits the K63-linked poly-ubiquitination and activation of TAK1. Together, our findings uncover an unrecognized mechanism by which LRRC62 antagonizes the activation of TAK1 in a CYLD-mediated deubiquitination-dependent manner, thereby balancing Toll-like receptor signaling to avert overzealous inflammation.
Insights
Leucine-rich repeat containing 62 (LRRC62) negatively regulates Toll-like receptor (TLR) signaling by inhibiting TGF-β-activated kinase 1 (TAK1) activation. This mechanism involves recruiting deubiquitinase CYLD to TAK1, averting excessive inflammation.
Area of Science:
- Immunology
- Molecular Biology
- Cell Signaling
Background:
- Toll-like receptor (TLR) signaling is crucial for innate immunity.
- The activation mechanisms of TGF-β-activated kinase 1 (TAK1), a key regulator in TLR pathways, are not fully understood.
- Understanding TLR signaling regulation is vital for controlling inflammatory responses.
Purpose of the Study:
- To identify novel regulators of TLR signaling.
- To elucidate the mechanism by which leucine-rich repeat containing 62 (LRRC62) modulates TAK1 activity.
- To investigate the role of LRRC62 in inflammatory cytokine production.
Main Methods:
- Investigated the role of LRRC62 in TLR signaling pathways.
- Assessed the impact of LRRC62 expression on pro-inflammatory cytokine production.
- Utilized molecular assays to determine the interaction between LRRC62, TAK1, and CYLD.
- Examined the effect of LRRC62 on NF-κB and MAPK signaling activation.
Main Results:
- LRRC62 negatively regulates TLR-induced pro-inflammatory cytokine production.
- LRRC62 deficiency enhances NF-κB and MAPK signaling activation.
- LRRC62 acts as an adaptor protein to recruit CYLD to TAK1.
- LRRC62 inhibits TAK1 activation by promoting CYLD-mediated deubiquitination.
Conclusions:
- LRRC62 is a novel negative regulator of TLR signaling.
- LRRC62 antagonizes TAK1 activation through CYLD-dependent deubiquitination.
- This pathway balances TLR signaling to prevent excessive inflammation.
More Related Videos
09:04Detection of Neu1 Sialidase Activity in Regulating TOLL-like Receptor Activation
Published on: September 7, 2010
07:55A Macrophage Reporter Cell Assay to Examine Toll-Like Receptor-Mediated NF-kB/AP-1 Signaling on Adsorbed Protein Layers on Polymeric Surfaces
Published on: January 7, 2020
Related Concept Videos
Transcription Attenuation in Prokaryotes
There are several different mechanisms used to attenuate transcription. In ribosome mediated...
Signal Sequences and Sorting Receptors
Insulin: The Receptor and Signaling Pathways
Yeast Signaling
Internal Receptors
Endocrine Signaling